About
Bancel holds a Master of Engineering from École Centrale Paris, a Master of Science in chemical engineering from the University of Minnesota and an MBA from Harvard Business School. He worked at Eli Lilly and Company from July 2000 to March 2006, including as managing director for Belgium, and was then chief executive of bioMérieux for five years before joining Moderna. Other pharmaceutical leaders with pages on Whoo include Albert Bourla of Pfizer and David Ricks of Eli Lilly.
Whoo compiled this page from public sources: Moderna investor relations, Moderna Q3 2026 results (SEC Form 8-K), Wikipedia. It is not affiliated with or endorsed by Stéphane Bancel. Are you Stéphane Bancel? Claim this page, or write to [email protected] to correct or remove it. Last updated: 2026-11-17. Photo: Xuthoria, CC BY-SA 4.0, via Wikimedia Commons.
Want a page like this? Create yours from your résumé.
Experience
Chief Executive Officer — Moderna
October 2011 – Present | Cambridge, Massachusetts
- Member of the Moderna board since March 2011
- Leads a company developing mRNA vaccines and therapeutics
- Led the diagnostics company before the move to Moderna
- Roles included Managing Director, Belgium, and Executive Director, Global Manufacturing Strategy and Supply Chain
- Held the regional sales and marketing role before joining Eli Lilly
Chief Executive Officer — bioMérieux
Five years before joining Moderna
Eli Lilly and Company
July 2000 – March 2006
Asia-Pacific Sales and Marketing Director — bioMérieux
Before Eli Lilly